Literature DB >> 8863276

Improvement of intestinal absorption of leucine enkephalin by sugar coupling and peptidase inhibitors.

T Mizuma1, K Ohta, A Koyanagi, S Awazu.   

Abstract

Peptidase-degradable leucine enkephalin (LE) was coupled with cellobiose or gentiobiose. In the absorption experiments, cellobiose-coupled LE (CcpLE) was more stable than LE itself on the mucosal side, and CcpLE appeared on the serosal side. Destyrosyl LE coupled with cellobiose was not formed, indicating that sugar coupling provided LE with aminopeptidase resistance. In the presence of inhibitors of angiotensin-converting enzyme and enkephalinase, the stability of CcpLE on the mucosal side was increased, and as a result more was absorbed. Furthermore, the absorption clearance was much higher than the value expected from the mucosal concentration of CcpLE. Similar results were observed in the absorption of gentiobiose-coupled LE. In the LE absorption experiment, however, LE was not detected on the serosal side even in the presence of these peptidase inhibitors. Improvement of intestinal absorption by sugar coupling and peptidase inhibitors was evaluated kinetically, indicating the exclusive contribution of metabolic degradation of LE through intestinal tissues to the absorption process.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8863276     DOI: 10.1021/js950507l

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  3 in total

1.  Development of novel lipophilic derivatives of DADLE (leucine enkephalin analogue): intestinal permeability characateristics of DADLE derivatives in rats.

Authors:  T Uchiyama; A Kotani; H Tatsumi; T Kishida; A Okamoto; N Okada; M Murakami; T Fujita; Y Fujiwara; Y Kiso; S Muranishi; A Yamamoto
Journal:  Pharm Res       Date:  2000-12       Impact factor: 4.200

2.  The Metabolic Inhibition Model Which Predicts the Intestinal Absorbability and Metabolizability of Drug: Theory and Experiment.

Authors:  Takashi Mizuma; Shoji Awazu
Journal:  Biol Proced Online       Date:  1998-05-14       Impact factor: 3.244

Review 3.  A review on the strategies for oral delivery of proteins and peptides and their clinical perspectives.

Authors:  Abdul Muheem; Faiyaz Shakeel; Mohammad Asadullah Jahangir; Mohammed Anwar; Neha Mallick; Gaurav Kumar Jain; Musarrat Husain Warsi; Farhan Jalees Ahmad
Journal:  Saudi Pharm J       Date:  2014-06-16       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.